Smerud Medical Research UK Limited - Limited company - abbreviated - 11.0.0

Smerud Medical Research UK Limited - Limited company - abbreviated - 11.0.0


05844549 1.1.13 31.12.13 31.12.13 Company accounts Private Limited Company FY true false true false true false false Ordinary 0.01000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure058445492012-12-31058445492013-12-31058445492013-01-012013-12-31058445492011-12-31058445492012-01-012012-12-31058445492012-12-3105844549ns12:England2013-01-012013-12-3105844549ns14:PoundSterling2013-01-012013-12-3105844549ns7:Director12013-01-012013-12-3105844549ns7:OrdinaryShareClass12013-01-012013-12-3105844549ns7:CompanySecretary2013-01-012013-12-3105844549ns7:RegisteredOffice2013-01-012013-12-3105844549ns7:EntityAccountantsOrAuditors2013-01-012013-12-3105844549ns5:FixturesFittings2013-01-012013-12-3105844549ns5:ComputerEquipment2013-01-012013-12-3105844549ns7:OrdinaryShareClass12013-12-3105844549ns7:OrdinaryShareClass12012-12-31
REGISTERED NUMBER: 05844549 (England and Wales)















SMERUD MEDICAL RESEARCH UK LIMITED

Abbreviated Unaudited Accounts for the Year Ended 31 December 2013






SMERUD MEDICAL RESEARCH UK LIMITED (REGISTERED NUMBER: 05844549)






Contents of the Abbreviated Accounts
for the Year Ended 31 December 2013




Page

Company Information 1

Abbreviated Balance Sheet 2

Notes to the Abbreviated Accounts 3

SMERUD MEDICAL RESEARCH UK LIMITED

Company Information
for the Year Ended 31 December 2013







DIRECTOR: Mr K Smerud





SECRETARY: Mrs H K Smerud





REGISTERED OFFICE: Suite 11NB Trafford House
Chester Road
Old Trafford
Manchester
M32 0RS





REGISTERED NUMBER: 05844549 (England and Wales)





ACCOUNTANTS: Whitehead & Co
Chartered Accountants
Registered Auditor
40 Lord Street
Stockport
Cheshire
SK1 3NA

SMERUD MEDICAL RESEARCH UK LIMITED (REGISTERED NUMBER: 05844549)

Abbreviated Balance Sheet
31 December 2013

31.12.13 31.12.12
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 2 1 272

CURRENT ASSETS
Debtors 296,486 171,871
Cash at bank and in hand 25,687 4,348
322,173 176,219
CREDITORS
Amounts falling due within one year 220,267 130,756
NET CURRENT ASSETS 101,906 45,463
TOTAL ASSETS LESS CURRENT
LIABILITIES

101,907

45,735

CREDITORS
Amounts falling due after more than one
year

206,650

130,000
NET LIABILITIES (104,743 ) (84,265 )

CAPITAL AND RESERVES
Called up share capital 3 1 1
Profit and loss account (104,744 ) (84,266 )
SHAREHOLDERS' FUNDS (104,743 ) (84,265 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2013.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2013 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.


The financial statements were approved by the director on 4 July 2014 and were signed by:



Mr K Smerud - Director


SMERUD MEDICAL RESEARCH UK LIMITED (REGISTERED NUMBER: 05844549)

Notes to the Abbreviated Accounts
for the Year Ended 31 December 2013

1. ACCOUNTING POLICIES

Accounting convention
The financial statements have been prepared under the historical cost convention and in accordance with the
Financial Reporting Standard for Smaller Entities (effective April 2008).

Turnover
Turnover represents net invoiced sales of services, excluding value added tax.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixtures and fittings - 25% on cost
Computer equipment - 33.33% on cost

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance
sheet date.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the
balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at
the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to the profit and loss account on a straight line basis over the
period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension
scheme are charged to the profit and loss account in the period to which they relate.

2. TANGIBLE FIXED ASSETS
Total
£   
COST
At 1 January 2013
and 31 December 2013 12,802
DEPRECIATION
At 1 January 2013 12,530
Charge for year 271
At 31 December 2013 12,801
NET BOOK VALUE
At 31 December 2013 1
At 31 December 2012 272

3. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.12.13 31.12.12
value: £    £   
100 Ordinary 0.01 1 1

SMERUD MEDICAL RESEARCH UK LIMITED (REGISTERED NUMBER: 05844549)

Notes to the Abbreviated Accounts - continued
for the Year Ended 31 December 2013

4. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Mr K Smerud.